A phase I study of the safety and possible toxicity of a novel ayurvedic preparation - Sudarshana Suspension
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Proceedings of Second International Conference on Natural Products Genomics and Drug Discovery, 2016
Abstract
Attached
Introduction: Sudarshana powder (SP) is a very effective anti-pyretic Ayurveda preparation. The extreme bitterness of this powder reduces the patient compliance and administration to children is very difficult. Therefore this powder was developed into a user-friendly standard Ayurveda suspension. Objective: The aim of this present study was to evaluate the safety/possible toxicity of the novel formulation, Sudarshana suspension (SS) in a group of healthy adult volunteers. Methodology: The study protocol was approved by the institutional ethics review committees and registered in Sri Lanka Clinical Trials Registry. Study was carried out in Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura. Healthy adult volunteers (n=35) of
Introduction: Sudarshana powder (SP) is a very effective anti-pyretic Ayurveda preparation. The extreme bitterness of this powder reduces the patient compliance and administration to children is very difficult. Therefore this powder was developed into a user-friendly standard Ayurveda suspension. Objective: The aim of this present study was to evaluate the safety/possible toxicity of the novel formulation, Sudarshana suspension (SS) in a group of healthy adult volunteers. Methodology: The study protocol was approved by the institutional ethics review committees and registered in Sri Lanka Clinical Trials Registry. Study was carried out in Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura. Healthy adult volunteers (n=35) of
Description
Keywords
Citation
Weerakoon, W.A.S.S., Perera, P.K., Gunasekera, D., Suresh, T.S. (2016). "A phase I study of the safety and possible toxicity of a novel ayurvedic preparation - Sudarshana Suspension", Proceedings of Second International Conference on Natural Products Genomics and Drug Discovery, 2016, p. 17